ABOUT THE CHALLENGE
About the Billion Dollar Challenge
Message from the President & CEO
Campaign Goals
Campaign Priorities
Campaign Milestones
Interactive Timeline
REASONS TO BELIEVE
Why you can Believe It
Innovation Spotlight
Archive Innovation Spotlight
Innovation Spotlight Archive
Immune Therapy
MOLECULAR PROFILING
Donor Spotlight
The Lewitt Family
Gordon Feeney
The Thomas Family
Emmanuelle Gattuso
The PMCF's Annual Report
Personalized Cancer Medicine
What is Personalized Cancer Medicine?
Key Investments
Funding by Cancer Type
TRANSFORMATIONAL GIFTS
NEWS & MEDIA
News Archive
Advertisements
Archive Advertisements
Getting Closer - Fall 2014
Surgeon Innovators - Fall 2013
Video gallery
KEY QUESTIONS
CONTACT US
Billion Dollar Challenge
About the Billion Dollar Challenge
Message from the President & CEO
Campaign Goals
Campaign Priorities
Campaign Milestones
Interactive Timeline
Campaign Goals
What will the Billion Dollar Challenge enable The Princess Margaret to do?
The Billion Dollar Challenge is our commitment to secure $1 Billion by 2017 to lead the creation and delivery of the new gold standard in cancer care: Personalized Cancer Medicine. Funds raised by the Billion Dollar Challenge will provide critical support in expanding:
PEOPLE AND PROGRAMS
Attract, retain and train world-class researchers, physicians and other staff in new and promising areas including:
-
Epigenetics
- Genetic Sequencing
-
Immune Therapy
-
Molecular Imaging
-
Nanotechnology
BUILDING
Expand and retrofit space at The Princess Margaret and at the Princess Margaret Cancer Research Tower to facilitate groundbreaking research and leading edge patient care. This is the largest-ever research expansion for The Princess Margaret, and will free up space at 610 and 620 University Avenue for additional clinical care.
TECHNOLOGY AND EQUIPMENT
Secure the equipment and technology that will allow The Princess Margaret to lead the way in delivering Personalized Cancer Medicine.
Find out more details by reading our
Campaign Priorities
.
Learn about the specific areas of cancer research we are advancing by reading
Key Investments
.